News About: Pharm. Industry
Drugmakers struggle for survival
Fierce competition in domestic ethical market is making it harder for companies to do business.
As the massive drug price cut plan is expected to take effect in April, analysts expect a large number of mergers and ...
Companies seeking to establish sound marketing order
Some companies are gaining favorable response from their salespeople, declaring that any ‘push’ sales activities to ensure achievement of sales target and money collection are no longer available.
This transition i...
Court’s final ruling due over drug price cuts
The Seoul Administrative Court is expected to make its final ruling on February 17 on a suit of seven pharmaceutical firms with the court against the Ministry of Health and Welfare for nullify its improper price cuts ...
Government urged to support pharmaceutical companies to gain global competitiveness
In addition to the rebate regulation solution, the Ministry of Welfare needs to find ways of supporting pharmaceutical companies to gain global competitiveness and at the same time, innovative incentives are needed to...
Concerns growing over Pfizer’s tactics to advance into generic market
Controversial tactics that Pfizer Korea is using to protect its revenue through selling of seven generic drugs could become a model for the domestic pharmaceutical industry as more multinational companies lose exclusi...
Daewoong’s Ursa commercials win acclaim in 2011
Daewoong Pharmaceutical Co.’s commercial for Ursa hepatic drug, in which footballer Cha Du-ri sang a catchy theme song, received the overwhelmingly positive reactions from viewers and the market last year, a poll show...
Why do salespeople commit suicide?
Pressure from poor performance is something unavoidable for salespersons and can bring about deadly consequences, if it's poorly managed.
Experts say the intensity of such pressure has increased in recent years du...
Court rejects NHIC’s compensation claim over drugmakers’ improper profit
A local court on Friday dismissed a compensation suit filed by the National Health Insurance Corp. against eight pharmaceutical firms for profiteering about 30 billion won.
The NHIC filed the suit, claiming these c...
Kwangdong announces product licensing agreement with Germany company
Kwangdong Pharmaceutical Co. said recently it entered into a commercial licensing agreement with German Based Engelhard Arzneimittel GmbH on an exclusive basis for distribution of an ivy leaf (photo) extraction produc...
Pfizer Korea is making all-out to go generic drugs
Pfizer Korea is moving into generics in a big way.
The company had quietly been turning out generic versions of some of Pfizer’s own off-patent products for a while, fearing the negative opinions of local pharmaceu...
